136 related articles for article (PubMed ID: 29987450)
1. EphB4 mediates resistance to antiangiogenic therapy in experimental glioma.
Uhl C; Markel M; Broggini T; Nieminen M; Kremenetskaia I; Vajkoczy P; Czabanka M
Angiogenesis; 2018 Nov; 21(4):873-881. PubMed ID: 29987450
[TBL] [Abstract][Full Text] [Related]
2. Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas.
Czabanka M; Bruenner J; Parmaksiz G; Broggini T; Topalovic M; Bayerl SH; Auf G; Kremenetskaia I; Nieminen M; Jabouille A; Mueller S; Harms U; Harms C; Koch A; Heppner FL; Vajkoczy P
Eur J Cancer; 2013 Jun; 49(9):2243-52. PubMed ID: 23499430
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic therapy inhibits the recruitment of vascular accessory cells to the perivascular niche in glioma angiogenesis.
Parmaksız G; Czabanka M; Vinci M; Vajkoczy P
J Vasc Res; 2014; 51(2):102-9. PubMed ID: 24556643
[TBL] [Abstract][Full Text] [Related]
4. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.
Acker G; Palumbo A; Neri D; Vajkoczy P; Czabanka M
J Neurooncol; 2016 Aug; 129(1):33-8. PubMed ID: 27188647
[TBL] [Abstract][Full Text] [Related]
5. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
[TBL] [Abstract][Full Text] [Related]
6. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
Erber R; Eichelsbacher U; Powajbo V; Korn T; Djonov V; Lin J; Hammes HP; Grobholz R; Ullrich A; Vajkoczy P
EMBO J; 2006 Feb; 25(3):628-41. PubMed ID: 16424904
[TBL] [Abstract][Full Text] [Related]
7. LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance.
Stange L; Lucia KE; Ghori A; Vajkoczy P; Czabanka M; Broggini T
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328529
[TBL] [Abstract][Full Text] [Related]
8. EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.
Huang X; Yamada Y; Kidoya H; Naito H; Nagahama Y; Kong L; Katoh SY; Li WL; Ueno M; Takakura N
Cancer Res; 2007 Oct; 67(20):9800-8. PubMed ID: 17942910
[TBL] [Abstract][Full Text] [Related]
9. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth and angiogenesis by soluble EphB4.
Martiny-Baron G; Korff T; Schaffner F; Esser N; Eggstein S; Marmé D; Augustin HG
Neoplasia; 2004; 6(3):248-57. PubMed ID: 15153337
[TBL] [Abstract][Full Text] [Related]
11. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
Kertesz N; Krasnoperov V; Reddy R; Leshanski L; Kumar SR; Zozulya S; Gill PS
Blood; 2006 Mar; 107(6):2330-8. PubMed ID: 16322467
[TBL] [Abstract][Full Text] [Related]
12. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
13. Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse.
Vajkoczy P; Schilling L; Ullrich A; Schmiedek P; Menger MD
J Cereb Blood Flow Metab; 1998 May; 18(5):510-20. PubMed ID: 9591843
[TBL] [Abstract][Full Text] [Related]
14. HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors.
Shojaei F; Lee JH; Simmons BH; Wong A; Esparza CO; Plumlee PA; Feng J; Stewart AE; Hu-Lowe DD; Christensen JG
Cancer Res; 2010 Dec; 70(24):10090-100. PubMed ID: 20952508
[TBL] [Abstract][Full Text] [Related]
15. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
[TBL] [Abstract][Full Text] [Related]
16. Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy.
Czabanka M; Vinci M; Heppner F; Ullrich A; Vajkoczy P
Int J Cancer; 2009 Mar; 124(6):1293-300. PubMed ID: 19101989
[TBL] [Abstract][Full Text] [Related]
17. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
[TBL] [Abstract][Full Text] [Related]
18. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
19. EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer.
Lv J; Xia Q; Wang J; Shen Q; Zhang J; Zhou X
Exp Mol Pathol; 2016 Jun; 100(3):402-8. PubMed ID: 27072105
[TBL] [Abstract][Full Text] [Related]
20. The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
Atzori MG; Tentori L; Ruffini F; Ceci C; Bonanno E; Scimeca M; Lacal PM; Graziani G
J Pharmacol Exp Ther; 2018 Jan; 364(1):77-86. PubMed ID: 29025978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]